QuantumCyte’s digital pathology approach targets a long-standing limitation in solid-tumor sequencing—low tumor purity in biopsies that prevents reliable extraction of actionable DNA. The AI-guided QCPRECISE platform identifies tumor borders on slides and applies a polymer mask to exclude surrounding healthy tissue, aiming to expand which patients can receive targeted therapy insights. On imaging triage, new diagnostic modeling work continues to emphasize interpretability and workflow fit. A separate advance describes an observer-performance trial for salivary gland ultrasound in which confidence-aware AI improved radiologists’ accuracy and agreement when distinguishing common benign parotid tumors. For acute care, new machine learning using early ICU windows targets mortality risk stratification, and additional pediatric-focused algorithms attempt to detect children likely needing intervention—highlighting a broader shift toward externally validated predictive models rather than standalone retrospective scores. Across these studies, the operational theme is consistent: better pre-analytic sampling, calibrated risk outputs, and UI-integrated decision support designed for clinicians’ real-time workflows.